Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Novartis Pharmaceuticals
Age
0–5
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Children aged 6 months - 5 years at Visit 1, with a documented history of hypertension
Must be able to swallow liquid formulation
Must be ≥ 6 kg or ≤ 40 kg at randomization
Must have documented history MSSBP (mean of 3 measurements) must be ≥ 95th percentile for age, gender and height, at randomization
If patients enter with uncontrolled BP they can remain on background antihypertensives with an unchanged dosing regimen
If patients have had a solid organ transplant more than 1 year ago they must be on stable doses of immunosuppressive therapy
Parent(s)/guardian(s) are able to follow verbal and/or written instructions in the local language
You may not be if
Patients with background ARB therapy
Patients demonstrating any clinically significant abnormalities or clinically noteworthy abnormal lab values (other than those relating to renal function)
AST/SGOT or ALT/SGPT \> 3 times the upper limit of the reference range
Glomerular filtration rate \< 30 mL/min/1.73m²
Serum potassium \> upper limit of the reference range